Amgen Inc.
AMGN
$336.74
$0.740.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.77% | 13.44% | 16.32% | 19.01% | 21.51% |
| Total Other Revenue | 5.97% | 0.86% | -0.37% | 9.22% | 15.53% |
| Total Revenue | 10.56% | 12.88% | 15.56% | 18.57% | 21.25% |
| Cost of Revenue | -14.28% | -7.57% | -0.47% | 8.33% | 43.78% |
| Gross Profit | 21.89% | 21.72% | 22.12% | 22.48% | 13.16% |
| SG&A Expenses | -0.41% | 2.20% | 11.74% | 24.67% | 27.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 111.54% | 403.90% | -74.84% | -61.02% | -183.54% |
| Total Operating Expenses | 2.19% | 3.52% | 8.06% | 17.19% | 22.55% |
| Operating Income | 28.48% | 33.89% | 31.41% | 21.15% | 18.55% |
| Income Before Tax | 76.19% | 110.61% | 53.05% | -41.32% | -46.53% |
| Income Tax Expenses | 175.95% | 103.80% | 23.20% | -54.39% | -62.11% |
| Earnings from Continuing Operations | 65.60% | 111.47% | 57.67% | -39.11% | -44.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.60% | 111.47% | 57.67% | -39.11% | -44.09% |
| EBIT | 28.48% | 33.89% | 31.41% | 21.15% | 18.55% |
| EBITDA | 17.96% | 25.61% | 28.87% | 26.37% | 28.00% |
| EPS Basic | 65.22% | 110.67% | 56.99% | -39.39% | -44.30% |
| Normalized Basic EPS | 48.30% | 44.37% | 28.91% | 12.72% | -6.96% |
| EPS Diluted | 65.58% | 110.32% | 56.45% | -39.60% | -44.44% |
| Normalized Diluted EPS | 48.29% | 44.17% | 28.53% | 12.58% | -7.09% |
| Average Basic Shares Outstanding | 0.28% | 0.33% | 0.37% | 0.37% | 0.28% |
| Average Diluted Shares Outstanding | 0.32% | 0.51% | 0.70% | 0.37% | 0.33% |
| Dividend Per Share | 5.74% | 5.71% | 5.67% | 5.63% | 6.60% |
| Payout Ratio | -0.36% | -0.50% | -0.33% | 0.74% | 0.91% |